Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer Excision Site”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07040683
What this trial is testing

Lower Extremity Graft Study (LEGS): A Multicentre Randomised Controlled Trial of Negative Pressure Wound Therapy Versus Conventional Dressings for Split-thickness Skin Grafts After Lower Leg Skin Tumour Excision

Who this might be right for
Skin TransplantationSkin GraftingSplit Thickness Skin Graft+9 more
Region Skane 232
Testing effectiveness (Phase 2)WithdrawnNCT00963664
What this trial is testing

Evaluation of Interferon-Lovastatin Therapy for Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
NeoPlas Innovation 250
Not applicableLooking for participantsNCT07111728
What this trial is testing

Intraoperative Margin Assessment in Breast Cancer With HSI-Raman

Who this might be right for
Breast Cancer
Istituti Clinici Scientifici Maugeri SpA 104
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT05257577
What this trial is testing

Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)

Who this might be right for
Breast CancerQuality of LifePatient Satisfaction+3 more
Tampere University Hospital 220
Testing effectiveness (Phase 2)UnknownNCT00553618
What this trial is testing

Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients

Who this might be right for
Metastatic Melanoma
University of Louisville 160
Not applicableStudy completedNCT00972010
What this trial is testing

Study to Evaluate Surgical Excision Margins in Malignant Breast Lumpectomies With the PEAK PlasmaBlade

Who this might be right for
Breast Cancer
Sarah Blair, M.D. 21
Not applicableLooking for participantsNCT05839912
What this trial is testing

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

Who this might be right for
Melanoma
Craig L Slingluff, Jr 66
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)Study completedNCT01667419
What this trial is testing

Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma

Who this might be right for
Melanoma
Hoffmann-La Roche 498
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT04418089
What this trial is testing

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Who this might be right for
Breast CancerChemotherapy Effect
Universitas Indonesia 60
Large-scale testing (Phase 3)Study completedNCT00002720
What this trial is testing

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 642
Large-scale testing (Phase 3)Ended earlyNCT04410445
What this trial is testing

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
Nektar Therapeutics 765
Testing effectiveness (Phase 2)Ended earlyNCT00184067
What this trial is testing

Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma

Who this might be right for
Melanoma
University of Southern California 23
Post-approval studies (Phase 4)Study completedNCT00616135
What this trial is testing

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastMammaplasty+1 more
Cytori Therapeutics 71
Not applicableLooking for participantsNCT06903468
What this trial is testing

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Who this might be right for
Ductal Carcinoma in SituBreast Cancer
University of Florida 50
Testing effectiveness (Phase 2)WithdrawnNCT01612910
What this trial is testing

Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery

Who this might be right for
Breast Cancer Female
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT01008527
What this trial is testing

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Who this might be right for
Melanoma
H. Lee Moffitt Cancer Center and Research Institute 22
Early research (Phase 1)Looking for participantsNCT07475572
What this trial is testing

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

Who this might be right for
Melanoma
Alvotech Swiss AG 120
Next Page